Diagnosis & Disease Information

Pharmacist holding a box of medicine

General Medicine

Five Things to Know About the New Drug Pricing Negotiations

By

Arthur Allen, Rachana Pradhan, and David Hilzenrath, KFF Health News

August 31, 2023

The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations.

Pediatric Cancer

Imbruvica Approved for Pediatric Patients With Chronic Graft-vs-Host Disease

By

Brian Park, PharmD

August 26, 2022

The expanded approval was based on data from the phase 1/2 iMAGINE trial.

As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants.

AlloHCT Following Treatment With PD-1 mAbs Beneficial in Classic Hodgkin Lymphoma

By

Colby Stong

April 9, 2021

An international, retrospective study was conducted to assess outcomes following alloHCT after PD-1 blockade in Hodgkin lymphoma.

Next post in Lymphoma

Novel immunotherapies and small molecule pathway inhibitors are transforming the standard of care for some of the most challenging lymphoma subtypes.

R-MegaCHOEP vs R-CHOEP-14 in Newly Diagnosed Aggressive B-Cell Lymphoma